SEARCH

SEARCH BY CITATION

References

  • Abrams, W. B. & H. M. Solomon: The human platelet as a pharmacologic model for the adrenergic neuron. The uptake and release of norepinephrine. Clin. Pharmacol. Ther. 1969, 10, 702709.
  • Bradford, M. M.: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248254.
  • Cozzi, N. V. & K. F. Foley: Rapid and efficient method for suspending cells for neurotransmitter uptake assays. Biotechniques 2002, 32, 486492.
  • Cozzi, N. V. & A. E. Ruoho: Radiosynthesis of [3H]methcathinone, an inhibitor of monoamine reuptake transporters. J. Labelled Cpd. Radiopharm. 1998, 41, 927933.
  • Cozzi, N. V., M. K. Sievert, A. T. Shulgin, P. Jacob III & A. E. Ruoho: Inhibition of plasma membrane monoamine transporters by β-ketoamphetamines. Eur. J. Pharmacol. 1999, 381, 6369.
  • Dean, B. & D. L. Copolov: Dopamine uptake by the human platelet: effects of dopamine receptor agonists. Eur. J. Pharmacol. 1989, 173, 165169.
  • Fersht, A.: Enzyme structure and mechanism, 2nd ed.. W. H. Freeman and Company, New York, NY, 1985.
  • Fleckenstein, A. E., H. M. Haughey, R. R. Metzger, J. M. Kokoshka, E. L. Riddle, J. E. Hanson, J. W. Gibb & G. R. Hanson: Differential effects of psychostimulants and related agents on dopaminergic and serotonergic transporter function. Eur. J. Pharmacol. 1999, 382, 4549.
  • Glennon, R. A., R. Young, B. R. Martin & T. A. Dal Cason: Methcathione (“Cat”): an enantiomeric potency comparison. Pharmacol. Biochem. Behav. 1995, 50, 601606.
  • Glennon, R. A., M. Yousif, N. Naiman & P. Kalix: Methcathinone: a new and potent amphetamine-like agent. Pharmacol. Biochem. Behav. 1987, 26, 547551.
  • Gobbi, M., M. Moia, L. Pirona, I. Ceglia, M. Reyes-Parada, C. Scorza & T. Mennini: p-Methylthioamphetamine and 1-(m-chlorophenyl)piperazine, two non- neurotoxic 5-HT releasers in vivo, differ from neurotoxic amphetamine derivatives in their mode of action at 5-HT nerve endings in vitro. J. Neurochem. 2002, 82, 14351443.
  • Gygi, M. P., A. E. Fleckenstein, J. W. Gibb & G. R. Hanson: Role of endogenous dopamine in the neurochemical deficits induced by methcathinone. J. Pharmacol. Exp. Therap. 1997, 283, 13501355.
  • Gygi, M. P., J. W. Gibb & G. R. Hanson: Methcathinone: an initial study of its effects on monoaminergic systems. J. Pharmacol. Exp. Therap. 1996, 276, 10661072.
  • Huang, X., D. Marona-Lewicka & D. E. Nichols: p-Methylthioamphetamine is a potent new non-neurotoxic serotonin-releasing agent. Eur. J. Pharmacol. 1992, 229, 3138.
  • Kaminski, B. J. & R. R. Griffiths: Intravenous self-injection of methcathinone in the baboon. Pharmacol. Biochem. Behav. 1994, 47, 981983.
  • Mamrova, G. P., B. V. Sherstiuk, D. V. Bogomolov, M. Ozdamirova Iu & A. Nikolkina Iu: [Epidemiologic analysis of ephedrone substance abuse in the Primorye territory]. Sud. Med. Ekspert. 2001, 44, 3032.
  • Markantonis, S. L., A. Kyroudis & A. H. Beckett: The stereoselective metabolism of dimethylpropion and monomethylpropion. Biochem. Pharmacol. 1986, 35, 529532.
  • McCann, U. D., D. F. Wong, F. Yokoi, V. Villemagne, R. F. Dannals & G. A. Ricaurte: Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428. J. Neurosci. 1998, 18, 84178422.
  • Metzger, R. R., G. R. Hanson, J. W. Gibb & A. E. Fleckenstein: 3-4-Methylenedioxymethamphetamine-induced acute changes in dopamine transporter function. Eur. J. Pharmacol. 1998, 349, 205210.
  • Molliver, M. E., U. V. Berger, L. A. Mamounas, D. C. Molliver, E. O'Hearn & M. A. Wilson: Neurotoxicity of MDMA and related compounds: anatomic studies. Ann. N. Y. Acad. Sci. 1990, 600, 649661; discussion 661–664.
  • Pigolkin Iu, I. & B. V. Sherstiuk: [The histopathology of ephedrone drug abuse]. Sud. Med. Ekspert. 1996, 39, 2628.
  • Qian, Y., A. Galli, S. Ramamoorthy, S. Risso, L. J. DeFelice & R. D. Blakely: Protein kinase C activation regulates human serotonin transporters in HEK-293 cells via altered cell surface expression. J. Neurosci. 1997, 17, 4557.
  • Ricaurte, G., G. Bryan, L. Strauss, L. Seiden & C. Schuster: Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals. Science 1985, 229, 986988.
  • Rudnick, G.: Mechanisms of biogenic amine neurotransmitter transporters. In: Neurotransmitter transporters: structure, function, and regulation. Ed.: M. E. Reith. Humana Press, Totowa, NJ, 1997, pp. 73100.
  • Schuster, C. R., M. Lewis & L. S. Seiden: Fenfluramine: neurotoxicity. Psychopharmacol. Bull. 1986, 22, 148151.
  • Scorza, C., R. Silveira, D. E. Nichols & M. Reyes-Parada: Effects of 5-HT-releasing agents on the extracellullar hippocampal 5-HT of rats. Implications for the development of novel antidepressants with a short onset of action. Neuropharmacology 1999, 38, 10551061.
  • Sitte, H. H., B. Hiptmair, J. Zwach, C. Pifl, E. A. Singer & P. Scholze: Quantitative analysis of inward and outward transport rates in cells stably expressing the cloned human serotonin transporter: inconsistencies with the hypothesis of facilitated exchange diffusion. Mol. Pharmacol. 2001, 59, 11291137.
  • Sparago, M., J. Wlos, J. Yuan, G. Hatzidimitriou, J. Tolliver, T. A. Dal Cason, J. Katz & G. Ricaurte: Neurotoxic and pharmacologic studies on enantiomers of the N-methylated analog of cathinone (methcathinone): a new drug of abuse. J. Pharmacol. Exp. Therap. 1996, 279, 10431052.
  • Wagner, G. C., K. Preston, G. A. Ricaurte, C. R. Schuster & L. S. Seiden: Neurochemical similarities between d,l-cathinone and d-amphetamine. Drug Alcohol Depend. 1982, 9, 279284.
  • Young, R. & R. A. Glennon: Cocaine-stimulus generalization to two new designer drugs: methcathinone and 4-methylaminorex. Pharmacol. Biochem. Behav. 1993, 45, 229231.
  • Young, R. & R. A. Glennon: Discriminative stimulus effects of S(-)-methcathinone (CAT): a potent stimulant drug of abuse. Psychopharmacology (Berl) 1998, 140, 250256.
  • Zhingel, K. Y., W. Dovensky, A. Crossman & A. Allen: Ephedrone: 2-methylamino-1-phenylpropan-1-one (Jeff). J. Forensic Sci. 1991, 36, 915920.